The Federal Circuit on Tuesday denied Apple Inc.’s request to expedite oral arguments in its appeal challenging the U.S. International Trade Commission’s decision banning the tech giant from selling Apple Watches equipped with a “blood oxygen” feature. This ruling comes as a significant development in the ongoing patent dispute between Apple and Masimo Corporation. The contested feature is a crucial component of the latest Apple Watch models, potentially impacting their sales significantly moving forward.
For further information, you can read the original report here.